Digital Treatment Solutions

March 18, 2026 by Leave a Comment
https://korean-electronics.com//inquiry


 [INQ. NO. 2603E07] Emocog Inc. is a digital healthcare platform that assesses and treats emotion and cognition. Starting with the development of Cogthera, which is software used as a medical device for mild cognitive impairment, Emocog covers the entire dementia cycle ― from prevention, to identification, and symptom improvement.

Digital Screening Tool for Early Detection of Cognitive Decline
MemoryPick is a digital screening tool that helps users to detect early signs of cognitive decline. It evaluates memory and executive function, which are the first cognitive areas to decline due to dementia, as well as subjective cognitive decline and depression.

At the end of the test, it provides an instant results report representing the user’s brain health. Based on the results, it recommends memory strategies to help people’s daily life and lifestyle habits to keep the brain healthy.
It is a responsive web-based online test that can be performed on various devices and operating systems through a QR or a URL.
The test takes only about five minutes, providing comfortable and easy-to-use content based on simple words and shapes.
It is able to improve the accuracy of the results through large-scale compliance data by accounting for differences in cognitive function based on age, education, gender, etc.

Digital Healthcare Treatment Device
Cogthera is a digital therapeutics (DTx) device for delaying cognitive decline in patients with mild cognitive impairment.
Cogthera constantly monitors patients’ cognitive functions and provides personalized cognitive training to strengthen their neural networks and increase their *cognitive reserve.
It was designated as an Innovative Medical Device by MFDS and became the first cognitive intervention treatment software for MCI to be designated as an Innovative Medical Device in Korea.

It features a conversation-based interface using vocal cues, made for the convenience of patients with early cognitive decline. The difficulty-level automatically adjusts based on the patient’s performance. It is designed for daily use under the guidance and prescription of a healthcare professional.
Emocog builds an ecosystem to care for the entire journey from screening, to diagnosis and treatment of dementia. To overcome the physical constraints of not being able to care for every patient every day, Emocog proposes innovative solutions utilizing digital technology.
 
korean-electronics.com | Blog Magazine of korean electronics, brands and Goods

Filed Under: Cover Story Tagged With:

Nail & Toenail Management Solutions

March 18, 2026 by Leave a Comment
https://korean-electronics.com//inquiry

[INQ. NO. 2603E05] VADICOS Plus is expanding its professional medical services, focusing on problem nail and toenail management solutions that transcend the boundaries between beauty and medical.
Starting as VADICOS, today VADICOS Plus has expanded its business to encompass specialized medical services in response to changing times and the demands of the medical field. It has also focused on establishing management standards and systems that enable hospitals and professionals to grow together.

Currently, VADICOS Plus provides integrated products, solutions, and education systems centered on problematic nail care, steadily expanding its collaboration base with medical institutions.
Its VADICOS Corrector (Ingrown Nail System) is a non-surgical, painless correction solution developed to minimize side effects and discomfort associated with excisional surgery. The corrective wire, made from a shape-memory alloy, exhibits both shape-memory recovery above a certain temperature and super elasticity.
Its ATOM Laser is a non-heating, painless medical device characterized by dual effects: a 405nm wavelength that induces antifungal activity and a 635nm wavelength that promotes blood circulation and regeneration. The system supports simultaneous irradiation of both feet to reduce treatment time and features a dual-monitor setup that allows users to visually confirm and adjust irradiation positions. Another strength is that it aims to improve mycosis while reducing the burden of side effects from drug treatment.

VADICOS Plus is also accelerating its expansion into overseas markets. Japan is the first export destination, where the company is preparing entry into the medical problematic nail care market through cooperation with Maruto, a Japanese company with a 100-year history.
In addition, the company plans to expand exports of non-surgical, painless correction and antifungal treatment solutions to Southeast Asian countries, where the burden of hospital treatment costs is relatively high. 
 
korean-electronics.com | Blog Magazine of korean electronics, brands and Goods

Filed Under: Cover Story Tagged With:

Vein Viewer

March 18, 2026 by Leave a Comment
https://korean-electronics.com//inquiry

[INQ. NO. 2603E04] MAJUTECH Inc., a company specializing in vein-viewer systems, is accelerating its expansion into global markets while strengthening its presence in domestic medical settings with its flagship product, the infrared vein viewer VeinVu 200.
Founded in 2015, MAJUTECH has advanced its vein-visualization technologies through more than 20 years of accumulated medical device development experience and continuous R&D, aiming to expand its business beyond simple vein-detection devices toward vascular analysis equipment.
VeinVu 200 is a medical device that uses infrared-based vein-imaging projection technology to clearly display vascular structures on the skin surface. In particular, its HD mode enables visualization of fine veins, while the Line mode intuitively highlights the centerline of veins, allowing medical professionals to quickly and accurately identify optimal sites during intravenous injections or blood collection. These features help reduce procedural burdens for clinicians and alleviate patient discomfort, especially among pediatric patients, older adults, and individuals with difficult venous access.

MAJUTECH is currently expanding the supply of VeinVu 200 primarily to university hospitals, general hospitals, and specialized hospitals in Korea. Leveraging performance, quality, and price competitiveness, the company is gradually strengthening its market position even while competing with global-leading companies.
In overseas markets, MAJUTECH has begun sales in approximately 20 countries, securing a stable export base through exclusive distribution agreements of three to five years in some regions. In addition, with the completion of European MDR registration, the company is progressively expanding into multiple European countries.

Building on the success of VeinVu 200, MAJUTECH is also preparing next-generation product development that extends beyond vein visualization to include technologies such as blood flow velocity measurement and vascular guidance functions. From 2026 onward, the company plans to sequentially introduce new medical device lineups, aiming to evolve into a specialized provider of comprehensive venous and vascular solutions.
 
 
korean-electronics.com | Blog Magazine of korean electronics, brands and Goods

Filed Under: Cover Story Tagged With:

Potential Generator

March 18, 2026 by Leave a Comment
https://korean-electronics.com//inquiry

[INQ. NO. 2603E03] REGENTECH, founded in January 2019, has grown from its roots in the distribution of medical devices and health functional foods. Initially, the company focused on the distribution of potential generators (electrotherapy medical devices) and identified market needs through communication with consumers.
In December 2021, the company established a production facility in Hanam, Gyeonggi Province. The company launched its upgraded potential generator, the ELCURE 1000, and officially entered the medical device manufacturing market.
Currently, the ELCURE 1000 has been installed in approximately 40 medical institutions in Korea, with over 100 units sold, providing pain relief and therapeutic benefits to numerous patients. Meanwhile, the company is steadily expanding its presence in the global market, with three units sold in both the USA and China, respectively.

Non-invasive Electrical Stimulation Medical Device
The ELCURE 1000 is a non-invasive electrical stimulation medical device utilizing high-voltage microcurrent technology. It provides solutions that help improve blood circulation, relieve pain, and promote cell regeneration.
Equipped with a display that allows users to monitor microcurrent levels in real time, it is effective in alleviating various pains ― including muscle pain, joint pain, and neuralgia. Certified as a Class-2 medical device by Korea’s Ministry of Food and Drug Safety, it boasts practicality and convenience, making it accessible to both medical professionals and general users.
REGENTECH plans to expand into the global market, targeting countries with large medical industries, such as the USA, China, and Japan. As a leading player in high-voltage electric potential therapy, Japan is attracting attention as a key market for testing the potential of its products.

“We provide technologies that activate the body’s natural healing abilities to assist in cellular regeneration, without resorting to artificialor chemical compounds or treatments.We hope that through our research and development of medical technology-intensive productsand services, provided safely and conveniently, we will be able to help many people,” commented the company’s CEO.
 
 
korean-electronics.com | Blog Magazine of korean electronics, brands and Goods

Filed Under: Cover Story Tagged With:

Korean Exporters Relentlessly Marketing Competitive Export Items

March 18, 2026 by Leave a Comment
https://korean-electronics.com//inquiry

Korea’s exports in February reached $67.45 billion, a 29.0% increase from the same month last year.
Semiconductors were the driving force behind Korea’s exports, reaching $25.16 billion in February, showing a remarkable 160.8% increase compared to the same month last year. This is in fact the highest monthly figure ever recorded. Semiconductor exports have remained above $20 billion for three consecutive months due to excess demand stemming from increased investment in artificial intelligence (AI), and the resulting surge in memory prices

In February, only five of Korea’s 15 major export items, including semiconductors, saw an increase in exports. Computers, wireless communication devices, ships, and biohealth were these items that saw export growth. Conversely, exports of automobiles and auto parts declined due to the Lunar New Year holidays. Exports of general machinery, petrochemicals, and steel also saw declines.
By region, exports increased in seven of the nine major export regions. Exports to the United States reached $12.85 billion, a 29.9% increase, marking the highest February performance ever. Exports to China also increased by 34.1% to $12.75 billion due to higher demand for semiconductors.

Following these achievements, Korean export manufacturing companies are continuously developing and launching new products. Companies are making every effort to achieve their export performance goals for this year, and are strategically engaging in research and development and market development.
MAJUTECH has advanced its vein-visualization technologies through more than 20 years of accumulated medical device development experience and continuous R&D, aiming to expand its business beyond simple vein-detection devices toward vascular analysis equipment.
At SEMICON KOREA 2026, SAMICK THK exhibited its NX-mobile AMR, an autonomous mobile robot (AMR) that combines a multi-joint robot with a humanoid-shape. The product performs various tasks based on a multi-joint robot. Two cameras mounted on the robot head provide three-dimensional perception of the surrounding environment, while hand cameras at the end of each joint capture the shape of the workpiece.

Union Medical recently showcased its key product lineup targeting the aesthetics and skincare markets, focusing on high-power laser equipment. Last year, it showcased the technological prowess of its existing products to both domestic medical professionals and international buyers.
 
 
korean-electronics.com | Blog Magazine of korean electronics, brands and Goods

Filed Under: Cover Story Tagged With:

Premium Skincare Device

February 10, 2026 by Leave a Comment
https://korean-electronics.com//inquiry

[INQ. NO. 2602E09] Healux Co, Ltd. is expanding its business into beauty devices, in addition to lifting threads. Its flagship device, HealfusionPRO, is a premium skincare device utilizing solution-based waterjet technology. The solution minimizes skin irritation while simultaneously removing impurities and improving skin condition.
HealfusionPRO features a 3D rotating tip, designed to provide three-dimensional care according to the skin’s curves. This allows the solution to be applied more evenly to the skin, and it focuses on providing a more precise treatment experience compared to the existing 2D devices.
The device is increasingly being adopted by dermatology departments and premium clinics in Korea. It is particularly popular among high-end clinics in the Gangnam and Cheongdam areas of Seoul, building brand trust through increased use.

Healux continues to achieve significant success in overseas markets. Currently, HealfusionPRO is being exported to Hong Kong, Turkey, the UK, and Mexico.
Healux is preparing to launch its Healfusion brand in the USA and Brazil. To this end, it is gradually developing product education materials and digital marketing contents tailored to the local markets. Furthermore, it is diversifying its business portfolio by expanding its export portfolio to include skin booster products like MESOGLORY.
This year, Healux plans to participate in major international exhibitions and conferences, starting with IMCAS Paris, followed by AMWC Monaco, Dubai Derma, Korea Derma, Cosmoprof Hong Kong, and the American Society of Medispa.
In particular, Healux plans to participate in the Be+Well exhibition in Las Vegas, USA, in June, marking the beginning of brand activities aimed at a full-scale entry into the U.S. market in the second half of the year.
Healux is a company providing various products and services in the medical aesthetics field, starting with the development and manufacturing of laser devices for skin treatment, and growing into a specialized company offering comprehensive anti-aging solutions. Founded in 2018 and headquartered in Seoul, Healux has expanded its global influence by distributing its products to approximately 60 countries worldwide.
 
 
korean-electronics.com | Blog Magazine of korean electronics, brands and Goods

Filed Under: Cover Story Tagged With:

Aesthetic Medical Devices

February 10, 2026 by Leave a Comment
https://korean-electronics.com//inquiry

[INQ. NO. 2602E08] Chungwoo Medical, a specialized aesthetic medical device manufacturer with 25 years of experience, develops and manufactures energy-based medical devices, including radiofrequency (RF) and high-intensity focused ultrasound (HIFU) ― using proprietary technology.
With approximately 30% of its workforce dedicated to research and development and approximately 20% of its revenue reinvested in R&D, Chungwoo Medical has focused on advancing its products with clinical efficacy, safety, and user convenience in mind.

Leveraging this technological prowess, Chungwoo Medical’s products are currently supplied to over 70 countries worldwide, including those in Asia, Europe, the Middle East, and the Americas. The company is steadily securing key global certifications, including the EU’s MDR, the U.S. FDA, and Brazil’s ANVISA, thereby building its credibility in the international market.
At KIMES 2026, Chungwoo Medical plans to showcase its new aesthetic medical devices targeting the global market on an international stage, and to actively pursue overseas export sales and new distribution partners. During the exhibition, the company will conduct consultations tailored to each country’s distribution structure and regulatory requirements, based on product competitiveness, core technologies, and clinical data. It aims to establish mid- to long-term global partnerships by linking follow-up meetings and contract negotiations after the exhibition.
The APOLEX Tite, a key product to be showcased at the exhibition, is a medical device utilizing the Inside Monopolar Radiofrequency (IMR) method. Its design utilizes a patented, ultra-small temperature-sensing cannula to deliver high-frequency current to tissue to induce coagulation.
The 18g cannula minimizes the incision area, and a real-time temperature sensor enables energy control approximately 5°C before the set temperature is reached, ensuring a more stable treatment environment.

Furthermore, the device measures and controls tissue impedance in real time during the procedure, minimizing the impact on surrounding tissue and reducing the risk of charring or burns.
The ELLISYS SENSE is a medical device that uses high-frequency current to induce tissue coagulation. It features a double-shot design that delivers thermal energy to two skin layers in a single shot. It utilizes a vacuum suction system to maintain stable contact with the skin, and by controlling the needle insertion depth, it ensures even energy delivery to the target layer. Accordingly, this reduces treatment time, providing a more precise treatment environment.

The CONTLEX SENSE is a non-invasive, high-intensity focused ultrasound (HIFU) device featuring precise energy control using a magnetic cartridge. The two-way round-trip irradiation method was applied to increase the efficiency of the procedure. The two types of handpieces – line type and pen type – are supplied to enable flexible application according to the area and purpose of treatment.
Chungwoo Medical is expanding its global business into South America, the Middle East, some Asian nations, the Unites States, and Europe. By entering the market with FDA and CE certifications, the company plans to enhance brand credibility and expand its reach. Furthermore, it intends to strengthen its distribution network in South America and the Middle East to meet the growing demand for its non-invasive, energy-based devices.
Meanwhile, Chungwoo Medical plans to expand its reach with global buyers and medical professionals by participating in major international exhibitions, including IMCAS Paris, IMCAS America, IMCAS Asia, and Dubai Derma, following its participation in KIMES 2026. By launching R&D-driven new products and securing global certifications, the company plans to gradually strengthen its position as a leading K-aesthetic medical device brand.

 
korean-electronics.com | Blog Magazine of korean electronics, brands and Goods

Filed Under: Cover Story Tagged With:

AI-Based Cervical Cancer Screening Solution

February 10, 2026 by Leave a Comment
https://korean-electronics.com//inquiry

[INQ. NO. 2602E07] NTL Healthcare Co., Ltd, a medical device company specializing in the early diagnosis of female cancers, is expanding its business in the global market through diagnostic solutions that combine medical technology and artificial intelligence (AI).
Since its first foray into the field of gynecological cancer diagnosis in Korea in 1996 with the introduction of ‘Cervicography,’ an analog-based cervical cancer screening system, NTL Healthcare has continuously advanced its remote screening system and AI-based diagnostic technology.
NTL Healthcare has focused on improving the accuracy and accessibility of cervical cancer screening, focusing on developing technologies that can provide the same quality of diagnosis even in settings with inadequate existing medical infrastructure.
Based upon this accumulated technological expertise, NTL Healthcare is currently building a female disease diagnostic platform centered on its AI-based cervical cancer screening solution, ‘CerviCARE® AI.’
CerviCARE® AI is medical software that uses deep-learning-based AI to analyze cervical lesion images, complementing the subjective judgment of the diagnostician and providing standardized analysis results.
CerviCARE® AI is designed to capture cervical lesions externally, and then use AI to detect and analyze them to classify their condition, thereby assisting in determining subsequent treatment options. This reduces variation across testing environments and readers, thereby contributing to increased diagnostic efficiency.

Furthermore, the solution is designed to integrate with remote diagnostic systems to support rapid decisions, even when a second opinion from an expert is required. It is also meaningful in terms of improving medical accessibility and expanding the scope of women’s health care, as it can also be utilized in environments where traditional medical facilities are lacking.
NTL Healthcare currently exports its products to approximately 20 countries and has been gradually expanding its global presence, focusing on Asian countries such as Thailand, Mongolia, and Vietnam. Building on this momentum, it is also pursuing expansion into low- and middle-income countries (LMICs) and the European market.
Through its participation in this KIMES exhibition, NTL Healthcare is seeking to discover new business partners and expand global partnerships through direct consultations with domestic and international medical device buyers, distributors, and hospital officials. Through on-site demonstrations and consultations, NTL Healthcare plans to directly demonstrate the product’s functionality and usability, incorporating market needs and the latest trends into future product development and marketing strategies.

NTL Healthcare is prioritizing Japan, Indonesia, and Australia as its key markets, and is expanding collaboration opportunities in countries with a high level of acceptance of new medical technology.
In particular, CerviCARE® AI is a solution that can be utilized both in regions with limited medical infrastructure and advanced medical environments. Its strength is evaluated as its ability to simultaneously ensure standardization and speed in the process of diagnosis.
NTL Healthcare plans to continue participating in various domestic and international medical device exhibitions and academic events, including MEDICA 2026. Through these activities, NTL Healthcare aims to strengthen its networking with global medical experts and the industry persons concerned, and further promote the technology’s clinical value and potential applications.
Based on these activities, NTL Healthcare plans to continue expanding its services to provide more efficient and standardized medical services in the field of female cancer diagnosis.


 
 
korean-electronics.com | Blog Magazine of korean electronics, brands and Goods

Filed Under: Cover Story Tagged With:

Digital Healthcare Solutions

February 10, 2026 by Leave a Comment
https://korean-electronics.com//inquiry

[INQ. NO. 2602E06] Miraclare is a company that develops and supplies digital healthcare solutions encompassing everything from oral and jaw health management to clinical environment care, leveraging its sensor technology and data analysis capabilities. It continues to expand its data-driven approach to healthcare, centered on electromyography (EMG) technology.
At the core of Miraclare’s solutions is precisely measuring and analyzing subtle movements that patients may not be aware of, such as temporomandibular jointmuscle activity during sleep, teeth grinding and clenching, and supplying such data to both medical professionals and users in a way that they can easily understand.
Miraclare has built a broad product portfolio, encompassing personal wearable devices, analysis equipment for hospitals and dental clinics, and medical consumables, striving for both technological excellence and practicality.
In particular, Miraclare is expanding its scope of application in clinical settings by developing customized care products, including eye protection patches, eye shields, and thermal care products, that prioritize hygiene, safety, and ease of use ― in consideration of repetitive medical environments.
In Korea, the company is introducing its ‘Goodeeps Monitoring’ primarily to local dental clinics, and is gathering real-use cases for hospitals and clinics. This service-based solution ― where patients borrow the device from the hospital, measure their sleep at home for two to three days, and then transmit the data to their medical practitioner’s account ― allowing medical professionals to utilize this data as objective consultation data, is gaining keen attention in the field.
Miraclare’s technological prowess is also gaining recognition in overseas markets. The personal wearable ‘Goodeeps’ achieved over 1,000% of its funding goal on the Taiwanese crowdfunding platform ZecZec, demonstrating market responsiveness.
Furthermore, Miraclare has signed a memorandum of understanding (MOU) with Ci Medical, Japan’s largest dental equipment distributor, and is pursuing an exclusive distribution agreement with the company, with annual sales of approximately KRW 630 billion. Through this agreement, Miraclare is establishing a distribution and sales base for Goodeeps and Goodeeps Monitoring products in Japan, while also securing substantial sales and clinical data.


 Teeth Grinding & Teeth Clenching Analysis Solution
At KIMES 2026, Miraclare will showcase its teeth grinding and teeth clenching analysis solution, Goodeeps Monitoring, to medical professionals and hospital staff, demonstrating its practicality and potential clinical application. The key objective of this exhibition is to clearly demonstrate that this rental monitoring system measures temporomandibular joint muscle activity during sleep and allows patients to utilize the results from their home tests for consultations and explanations at the hospital.
Miraclare’s primary target markets are Japan, Taiwan, Southeast Asia, and parts of Europe. Japan is a market with strong interest in data-driven medical solutions, and the company aims to collaborate with potential partners in the nation for specialized medical practices such as dentistry and ophthalmology, as well as Taiwan, with its high acceptance of digital healthcare products.

With an eye on Taiwan, Miraclare is pursuing market expansion through crowdfunding and collaboration with medical distribution partners. In Europe and Southeast Asia, the company plans to collaborate with local buyers and medical consumable distribution partners, focusing on eye protection and clinical environment care products for dental, ophthalmology, and surgical settings.
Following KIMES 2026, Miraclare plans to expand the adoption of Goodeeps Monitoring in hospitals and increase its global presence by participating in overseas medical exhibitions and academic events. Focusing on Japan, Taiwan, Southeast Asia, and the Middle East, Miraclare plans to expand its network with local buyers and hospital staff, and gradually implement product localization and certification procedures. In the long term, it plans to achieve sustainable growth in the global medical and healthcare market through an integrated portfolio that combines data-driven oral and jaw health management solutions and medical environmental care products.


 
korean-electronics.com | Blog Magazine of korean electronics, brands and Goods

Filed Under: Cover Story Tagged With:

Stem Cell Extraction System

February 10, 2026 by Leave a Comment
https://korean-electronics.com//inquiry

[INQ. NO. 2602E05] Miracell Co., Ltd. is a stem cell company specializing in stem cell-based regenerative medicine, accumulating unparalleled technological prowess.
Miracell’s proprietary stem cell extraction system, Smart M-Cell, and its dedicated kit are medical devices approved by Korea’s Ministry of Food and Drug Safety as stem cell products. Having received FDA registration and CE certification, the system meets global regulatory standards and is characterized by their ability to extract high-quality multi-cells with maximized stem cell viability.
Smart M-Cell is a system that automatically extracts and concentrates stem cells from blood or bone marrow, achieving cell viability rates of up to 99%. It can simultaneously extract more than five key regenerative cell types, including stem cells, growth factors, white blood cells, and SDF-1α, making it ideal for customized regenerative medicine treatments tailored to specific treatment goals.
Currently, Smart M-Cell is used in over 600 hospitals and clinics in Korea and in over 40 countries worldwide.

Miracell’s technological prowess and reliability have been recognized through global deployments spanning Europe, the Middle East, Asia, and the Americas.
Smart M-Cell’s applications are expanding beyond knee joint treatment to include brain function enhancement, skin improvement, and cosmetic and plastic surgery procedures. Considering the importance of stem cell extraction systems, a key component in regenerative medicine, Smart M-Cell is considered a foundational technology that enhances treatment consistency and efficiency.
Miracell is also introducing the ‘Chroma M-Cell,’ a next-generation solution designed to maximize the effectiveness of stem cell treatment. Chroma M-Cell is the world’s first ringer bag-covered device that utilizes photobiomodulation technology to enhance cell vitality during stem cell ringer injection.
The device’s core function is to enhance cellular physiological activity and stabilize cell instability when exposed to the external environment by irradiating it with light of a specific wavelength. Four wavelengths — red, blue, yellow, and green — can be selected based on the treatment objective, enabling the product’s applications to be further expanded into diverse fields such as regenerative medicine, skin regeneration, and immune enhancement. Chroma M-cell, used in conjunction with Smart M-cell, is positioned as a complementary solution that elevates the effectiveness of stem cell treatment.
Miracell is actively targeting Russia, South America, China, and Japan as key target markets and is actively pursuing the global regenerative medicine market. The company is pursuing global standardization of Smart M-cell, focusing on countries where demand for stem cell treatment is rapidly growing due to aging populations and the rise of chronic diseases.

China and Russia, in particular, are considered markets with a high level of acceptance of alternative treatments, while South America is seen as a market with growing demand for combined aesthetic and regenerative medicine treatments. Japan, with its strong institutional support for regenerative medicine, is expected to have a high potential for early market penetration.
Miracell plans to actively promote Korea’s stem cell extraction technology, focusing on Smart M-Cell and Chroma M-cell, at major global exhibitions such as IMCAS (Paris), Dubai Stem Cell Congress, AAOS 2026, Dubai Derma 2026, INTERCHARM Moscow, and MEDICA (Düsseldorf). Through this, the company’s strategy is to verify its technological prowess, safety, and scalability on the international stage and further strengthen its position as a global platform company in the field of regenerative medicine.
 
 
korean-electronics.com | Blog Magazine of korean electronics, brands and Goods

Filed Under: Cover Story Tagged With:
«Previous Page
Next Page»